10x Genomics, Inc. TXG Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$22.66M+85.6% | -$43.54M+76.2% | -$76.32M+58.2% | -$84.6M+64.7% | -$157.04M+40.6% | ||
| $38.13M+9.9% | $36.2M+0.9% | $34.88M-5.3% | $33.55M-9.9% | $34.71M-9.2% | ||
| $100.68M-25.8% | $109.12M-22.5% | $116.44M-20.9% | $124.76M-18.9% | $135.7M-15.7% | ||
| $127.82M— | $136.05M— | —— | —— | —— | ||
| $5.64M-50.4% | $5.94M-52.1% | $6.87M-47.6% | $10.08M-58.8% | $11.38M-75.8% | ||
| -$12.86M+71.5% | -$13.44M+58.8% | -$63.23M-297% | -$58.04M-243% | -$45.16M-258% | ||
| -$2.04M-121% | $6.8M-37.7% | $9.08M-24.4% | $8.62M-46.9% | $9.7M-48.2% | ||
| $113.22M+432% | $129.9M+954% | $34.55M-58.6% | $17.89M— | $21.28M— | ||
| $122.18M— | $130.12M— | $81.65M— | $56.88M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does 10x Genomics, Inc.'s cash flow data come from?
- Every line is extracted from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.